Thiara Parvinder's Form 4 filing
Tourmaline Bio, Inc. (TRML) · filed Oct 26, 2023
- Accession no.
- 0001209191-23-053670
- Filed
- Oct 26, 2023
- Trade date
- Oct 24-25, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market purchases total $77.5K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thiara ParvinderCIK 0001995535 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 24, 2023 | Common Stock | PPurchaseAcquired | +5,000 | $10.66 | +$53,300 | 80,782 | Direct | |
| Oct 25, 2023 | Common Stock | PPurchaseAcquired | +2,000 | $12.12 | +$24,240 | 82,782 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.